Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H41NO3 |
Molecular Weight | 343.5444 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCC[C@H](O)[C@H](CO)NC(C)=O
InChI
InChIKey=CRJGESKKUOMBCT-PMACEKPBSA-N
InChI=1S/C20H41NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(24)19(17-22)21-18(2)23/h19-20,22,24H,3-17H2,1-2H3,(H,21,23)/t19-,20-/m0/s1
DescriptionSources: http://adisinsight.springer.com/drugs/800004732Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/8253743
Sources: http://adisinsight.springer.com/drugs/800004732
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/8253743
Cedefingol is a derivative of sphingosine, with potential antineoplastic activity. As a sphingosine derivative, cedefingol appears to inhibit protein kinase C (PKC), a kinase that plays an important role in tumorigenesis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096620 Sources: http://adisinsight.springer.com/drugs/800004732 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8253743
HL-60 human myelocytic leukemia cells were grown as described and treated with [3H]C2-ceramidesa t concentrations ranging from 1 to 10 mkM. At the indicated time points, pellets were separated from media and 3H radioactivity was counted.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C274
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7072
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
EE-60
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
81HH79X39W
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104082
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
9928060
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
C78081
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
35301-24-7
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
SUB06161MIG
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY | |||
|
100000081355
Created by
admin on Fri Dec 15 16:28:55 GMT 2023 , Edited by admin on Fri Dec 15 16:28:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY